Safety requirements for maintenance and distribution of transgenic mice susceptible to human viruses: the example of poliovirus-susceptible transgenic mice.
Ghendon
Y
Y
World Health Organization, Geneva, Switzerland.
Lambert
P H
PH
D000818:Animals; D003264:Containment of Biohazards / Q000379:methods*; D016679:Genome, Viral; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic / Q000821:virology*; D011051:Poliomyelitis / Q000209:etiology; D017955:Poliovirus / Q000235:genetics / Q000472:pathogenicity*; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects; D011634:Public Health; D012307:Risk Factors; D014774:Virulence
D011055:Poliovirus Vaccine, Oral